- BT.com
- At home
- Business
- UK Large business & public sector
- BT Group
- Choose Country or Region : United Kingdom
Jump to:
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and learn what you can do to make your experience on this site better.
Numerous challenges face today’s pharmaceutical industry – fierce competition from off-patent generic drugs; damage to profits and brand reputation from illegal and substandard copycats; FDA pressure to warrant the pedigree of a drug and ensure that consumers can easily identify industry-approved products.
Faced with these challenges, there is great urgency for pharmas and their manufacturing partners to re-address the security, efficiency and visibility of their supply chains. The distribution of products, from manufacturer to end-user, takes much consideration, design and validation. For example, control of storage and transportation temperatures is vital.
BT Safety Chain is an independent, integrated solution that can track the quality and integrity of your products across the supply chain, quickly trace and resolve manufacturing and distribution problems to minimise cost penalties and reduce counterfeiting by authenticating your drug pedigree in accordance with industry standards. This can help you improve patient safety and supply chain integrity.
Using unique serial numbers, secure databases and tracking technology, manufacturers, distributors and wholesalers can accurately trace and monitor pharmaceutical products. These additional levels of control can help you recall products more efficiently and meet your regulatory requirements. By scanning products at every point throughout the lifecycle, you can identify and eliminate potentially unsafe medicines from the marketplace and safeguard patient safety.
To find out more about how we can secure your pharmaceutical supply chain visit BT Safety Chain
-
BT Safety Chain - improving patient safety
- BT Safety Chain enables pharma to monitor their supply chain with powerful tracking and authentication technology, helping to conform to new regulatory measures, eliminate potentially unsafe medicines from the marketplace and maintain brand integrity.
-
